Home › NCT06934603
Microplastic Exposure From Clear Aligner Wear (MPE)
RecruitingObservational study
Microplastic Exposure From Clear Aligner Wear: An In Vivo, Longitudinal Study of Orthodontic Patients
Who can join
Ages 10 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria: * Individuals (all sexes, genders, races, and ethnicities) aged at least 10 years (in adult dentition) and at most 75 years * Receiving comprehensive, Phase II orthodontic treatment with clear aligner therapy * Stable physical health (ASA I or II), as determined by study coordinator or PI * Able to comprehend and follow requirements of study (including availability on scheduled visit dates) * Patient and parental consent (and assent for minors) for participation in the study Exclusion Criteria: * Receiving orthodontic treatment with fixed appliances * Receiving hybrid treatment with fixed appliances and aligners * Receiving Phase I orthodontic treatment with fixed appliances * Established history of severe xerostomia (dry mouth), severe periodontal disease with actively bleeding gums, significant oral abrasions/ulcers or growths, current alcohol abuse, and/or recreational drug abuse * Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase risk associated with participation * Drinking, eating, or brushing teeth within 1 hour of study visit * Removing aligners within 1 hour of study visit * Developmental or cognitive disability such that the patient cannot self-consent, comprehend, and follow the requirements of the study based on research site personnel's assessment
About the study
An observational longitudinal study measuring microplastic exposure and physiologic uptake in orthodontic patients receiving clear aligner treatment.
What is being tested
- Clear Aligner Treatment (other)
Sponsor: University of North Carolina, Chapel Hill · Participants: 150 · Started: Aug 8, 2025
Contact the study team
- Laura A Jacox, DMD, PhD, MS · Phone: 919-537-3424
- S.T. Phillips, BSDH · Phone: 919-537-3422
Official record on ClinicalTrials.gov — NCT06934603
Locations in the U.S.
| North Carolina | University of North Carolina at Chapel Hill, Chapel Hill |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.